To explore whether the immune cell subsets of tumor tissues with high expression of ICOSLGTCs in OSCC patients changed, we determined the ICOSLG, CD4, CD8, CD19, CD68 and Foxp3 level of tumor centers and infiltration fronts in serial sections (Figures 5A,B). The gene discussed is ICOSLG; the disease is neoplasm.